Questions discussed in this category
E.g., a patient with newly diagnosed CIDP who is wheelchair-bound.
How do you differentiate symptoms related to centralized pain syndrome from possible cognitive dysfunction?
Do you attempt to taper fully or maintain at a low dose?
Do you wait 12 weeks for confirmation to begin treatment if patient is declining?
When it seems fairly certain that this is a drug effect is it something that can just be monitored or requires a change in approach?
Do you just use antibiotic prophylaxis if therapy is started prior to meningococcal vaccination?
Specifically, how do you treat the delayed headache, not the headache that develops during the infusion where pre-hydration and slowing down the rate ...
186651577416950173991640611535152251514712639148141412811620107901114599119751
Papers discussed in this category
Arthritis and rheumatism, 2001-12
Journal of neurovirology, 2018-06
Arthritis Res Ther, 2021 Mar 22
Clin Microbiol Infect, 2018 Feb 07
Pediatr Blood Cancer, 2021 Oct
Arthritis and rheumatism, 2010-05
Ann Clin Transl Neurol, 2020 Jul 06
Lupus, 2023 Apr 10
Lupus Sci Med, 2022 Jan